We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
Cap. Flow
+$648M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$400M
2
STZ icon
Constellation Brands
STZ
+$345M
3
META icon
Meta Platforms (Facebook)
META
+$286M
4
KVUE icon
Kenvue
KVUE
+$277M
5
ABBV icon
AbbVie
ABBV
+$258M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 13.22%
3 Consumer Discretionary 12.71%
4 Financials 7.66%
5 Communication Services 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLAY icon
376
Dave & Buster's
PLAY
$343M
$29.4M 0.04%
469,810
+391,375
+499% +$22.4M
OIH icon
377
VanEck Oil Services ETF
OIH
$2.06B
$29.4M 0.04%
87,346
+21,605
+33% +$6.55M
ATRC icon
378
AtriCure
ATRC
$1.77B
$29.2M 0.04%
961,359
+525,946
+121% +$17.6M
CL icon
379
Colgate-Palmolive
CL
$72.6B
$29.1M 0.04%
323,034
-1,733,501
-84% -$147M
MSFT icon
380
PUT
Microsoft
MSFT
$2.84T
$29.1M 0.04%
69,800
-127,300
-65% -$51.5M
HRI icon
381
Herc Holdings
HRI
$5.43B
$29.1M 0.04%
+172,616
New +$26.3M
UTHR icon
382
United Therapeutics
UTHR
$26.3B
$28.9M 0.04%
125,643
+115,788
+1,175% +$26.1M
INDA icon
383
iShares MSCI India ETF
INDA
$6.71B
$28.7M 0.04%
555,747
+115,284
+26% +$5.81M
NUE icon
384
Nucor
NUE
$56.4B
$28.7M 0.04%
144,850
-186,439
-56% -$34.1M
GO icon
385
Grocery Outlet
GO
$891M
$28.5M 0.04%
991,963
+63,586
+7% +$1.68M
LNTH icon
386
Lantheus
LNTH
$6.82B
$28.4M 0.04%
457,062
+52,381
+13% +$3.08M
MAT icon
387
Mattel
MAT
$4.17B
$28.4M 0.04%
1,435,935
+34,174
+2% +$648K
GMAB icon
388
Genmab
GMAB
$17.7B
$28.4M 0.04%
949,425
+734,017
+341% +$21.6M
IWF icon
389
iShares Russell 1000 Growth ETF
IWF
$122B
$28.3M 0.04%
+335,872
New +$27.1M
PTGX icon
390
Protagonist Therapeutics
PTGX
$8.75B
$28.3M 0.04%
976,893
+834,423
+586% +$22.7M
SHAK icon
391
Shake Shack
SHAK
$2.3B
$28.1M 0.04%
270,514
-149,259
-36% -$13.1M
BAC icon
392
CALL
Bank of America
BAC
$435B
$28.1M 0.04%
730,700
+730,600
+730,600% +$25.1M
PANW icon
393
CALL
Palo Alto Networks
PANW
$264B
$28.1M 0.04%
+186,400
New +$29.4M
COLD icon
394
Americold
COLD
$4.09B
$28M 0.04%
1,124,918
+55,416
+5% +$1.51M
HTGC icon
395
Hercules Capital
HTGC
$2.94B
$27.7M 0.04%
1,499,164
-314,758
-17% -$5.59M
ROP icon
396
Roper Technologies
ROP
$36.3B
$27.7M 0.04%
49,302
+31,986
+185% +$17.5M
TER icon
397
Teradyne
TER
$54.8B
$27.6M 0.04%
244,844
-78,202
-24% -$8.15M
EBAY icon
398
eBay
EBAY
$48.6B
$27.6M 0.04%
+523,154
New +$23.8M
SBUX icon
399
Starbucks
SBUX
$118B
$27.6M 0.04%
301,740
+230,587
+324% +$21.4M
ADI icon
400
Analog Devices
ADI
$181B
$27.4M 0.04%
+138,672
New +$26.7M

Similar funds

Marshall Wace's Q1 2024 Portfolio in Review

As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
  • Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
  • Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
  • Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
  • Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
  • Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.